HB5421

The 340B Integrity Act regulates 340B covered entities' use of 340B drugs and profits in Illinois.

The 340B Integrity Act mandates that starting January 1, 2027, 340B covered entities cannot bill Medicaid for 340B drugs. Beginning July 1, 2026, these entities must use 80% of their 340B profits to reduce out-of-pocket costs for low-income patients. The remaining profits must be used for free and discounted care for low-income patients. Starting September 1, 2026, 340B covered entities must annually report to the Department of Insurance on their use of 340B drugs, including costs, payments, and prescriptions. The Department must post these reports on a public website.